{"id":"NCT00834106","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)","officialTitle":"A Randomized, Placebo-Controlled, Double-Blind Study of Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine to Investigate the Safety, and Efficacy in Chinese 20 - to 45-Years-Old Women","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-12-31","primaryCompletion":"2012-05-11","completion":"2016-09-30","firstPosted":"2009-02-03","resultsPosted":"2017-10-12","lastUpdate":"2019-02-04"},"enrollment":3006,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["HPV Infections"],"interventions":[{"type":"BIOLOGICAL","name":"Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine","otherNames":["Gardasil â„¢","V501"]},{"type":"BIOLOGICAL","name":"Comparator: placebo (unspecified)","otherNames":[]}],"arms":[{"label":"qHPV","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"A study to test the safety and effectiveness of Quadrivalent HPV (types 6, 11, 16, 18) L1 VLP vaccine against combined incidence of HPV 6/11/16/18-related persistent infection and vaccine type-specific genital disease among Chinese females between the ages of 20 and 45.","primaryOutcome":{"measure":"Base Study: Combined Incidence of 6-Month Persistent Infection, Cervical Intraepithelial Neoplasia (CIN+), and External Genital Lesions Related to Human Papillomavirus (HPV) Type 6, 11, 16, or 18 in 20 to 45 Year Old Participants (Test of Hypothesis)","timeFrame":"From Day 1 until >=25 cases accumulate, up to Month 30","effectByArm":[{"arm":"qHPV","deltaMin":0.3,"sd":null},{"arm":"Placebo","deltaMin":1.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"20 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["30122646","30638797"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":38,"n":1499},"commonTop":["Injection Site Pain","Pyrexia","Fatigue","Headache","Myalgia"]}}